Aquestive Therapeutics, Inc. ( AQST) - Stock Earnings
AQST Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 10, 2026, midnight | — / — | — | — / — | — |
AQST Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -15.4 million USD | 12.8 million USD |
| 2025Q4 | -31.9 million USD | 13.0 million USD |
| 2026Q1 | -8.1 million USD | 14.4 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
AQST Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -7.9 million USD | 50.6 million USD |
| 2024 | -44.1 million USD | 57.6 million USD |
| 2025 | -83.8 million USD | 44.5 million USD |
| 2026 Est. | — | — |
AQST
Price: $4.03
Earnings Per Share: -0.61 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 208846
Market Capitalization: 421.1 million